Caissa Capital Management ltd. (CIK 0001929354)

Latest company ownership

Shares held
0
Last filed at
Jun 27, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 26, 2023 Jun 27, 2023 Avalo Therapeutics, Inc. 10% Owner Sell 17.5 -1,608,000 -100.00% $1M
Jun 15, 2023 Jun 20, 2023 Avalo Therapeutics, Inc. 10% Owner Buy 68.8 +8,160 0.51% $31.6K
Jun 12, 2023 Jun 14, 2023 Avalo Therapeutics, Inc. 10% Owner Buy 82.5 +16,899 1.07% $63.6K
Jun 7, 2023 Jun 9, 2023 Avalo Therapeutics, Inc. 10% Owner Buy 72.5 +14,426 0.92% $56.4K
May 31, 2023 Jun 2, 2023 Avalo Therapeutics, Inc. 10% Owner Buy 55.0 +844 0.05% $2.4K
May 25, 2023 May 30, 2023 Avalo Therapeutics, Inc. 10% Owner Buy 55.0 +2,671 0.17% $7.5K
May 24, 2023 May 24, 2023 Avalo Therapeutics, Inc. 10% Owner Buy 68.8 +9,000 0.58% $26.8K
May 18, 2023 May 22, 2023 Avalo Therapeutics, Inc. 10% Owner Buy 82.5 +26,621 1.74% $89.4K
May 12, 2023 May 16, 2023 Avalo Therapeutics, Inc. 10% Owner Buy 61.3 +4,379 0.29% $11K
May 4, 2023 May 8, 2023 Avalo Therapeutics, Inc. 10% Owner Buy 82.5 +25,000 1.67% $69.4K
Apr 25, 2023 Apr 27, 2023 Avalo Therapeutics, Inc. 10% Owner Buy 68.8 +7,500 0.50% $22.4K
Apr 20, 2023 Apr 24, 2023 Avalo Therapeutics, Inc. 10% Owner Buy 82.5 +17,500 1.19% $53.7K
Apr 17, 2023 Apr 18, 2023 Avalo Therapeutics, Inc. 10% Owner Buy 82.5 +25,000 1.72% $73.9K
Apr 10, 2023 Apr 11, 2023 Avalo Therapeutics, Inc. 10% Owner Buy 87.5 +56,329 4.04% $142.5K